Oral Controlled Release Drug Delivery Technology Market

Oral Controlled Release Drug Delivery Technology Market: Diffusion Controlled Release System Anticipated to be the Most Attractive Segment During the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Ask The Analyst Customization Available Request Methodology

Large-scale requirement of anti-hypertensive drugs and higher adoption of combination approaches drive the global oral controlled release drug delivery technology market

The increase in generic drug consumption is driven by rising access to healthcare facilities and is fuelling the need for faster availability of drugs in oral solid dosages. This in turn fuels the need for application of controlled release technology, which could increase the availability of the drugs in reduced dosages. Further, with many big drug makers establishing a local manufacturing presence across various regions, the adoption of controlled release technology is expected to witness a growing spiral in the coming years especially in countries such as Brazil, Argentina, Costa Rica and Mexico.

The combination of various technologies helps in rapidly overcoming problems associated with poorly soluble candidates. This is being aided through greater technology sharing through various conferences and symposiums where companies sharing similar thought processes meet and plan eventual outcomes. This helps in better pricing and rapid time to market for the otherwise unviable products in the short run. A higher adoption of combination approaches is expected to boost the global market for oral controlled release drug delivery technology.

Increasing approvals of modified and extended release oral dosage forms by PMDA is likely to drive the growth in revenue of the Japan oral controlled release drug delivery technology market. In the case of new approvals, high preference towards tablets and capsules has been observed, as formulation scientists find it easy to create formulations for clinical as well as therapeutic use. Moreover, when compared to western countries such as the U.S. and Germany, Japan offers greater variety in the choice of oral solid dosage forms due to increased accessibility to local formulations. Large-scale requirement of anti-hypertensive drugs are likely to boost the market growth to a great extent. The large-scale requirement of anti-hypertensive drugs is fuelling the need for more companies to set up plants deploying controlled release technologies. The requirement is more for technology adoption of OROS and SODAS. Indigenous development of pharmaceutical infrastructure is a very important factor expected to fuel revenue growth of the oral controlled release drug delivery technology market.

Diffusion and Dissolution are the most preferred controlled release systems, representing a lucrative market opportunity for manufacturers of oral controlled release drug delivery technologies

The Dissolution Controlled Release System segment dominated the global oral controlled release drug delivery technology market in terms of revenue in 2017, and the trend is projected to continue throughout the forecast period. Dissolution Controlled Release System is the most attractive segment, with an attractiveness index of 3.6 over the forecast period. This segment accounted for close to 45% value share in 2017 and is projected to hold about 50% share by 2027 end. The Others segment, which includes upcoming technologies such as nanotechnology and other advanced matrix technologies is also growing at an exponential rate in terms of revenue in 2017 and the trend is projected to sustain throughout the forecast period. The Others segment is the most attractive segment, with a market attractiveness index of 0.6 over the forecast period.

oral-controlled-release-drug-delivery-technology-market

Controlled Release Formulations – A common strategy to extend the product life cycle

Controlled Release is the most common strategy adopted by pharma giants across the globe to extend the product life cycle. Modified or controlled release formulations of pre-approved drugs are enjoying extended market exclusivity. The introduction of proprietary prescribed medicines in controlled release forms will help drive revenue growth of the global market. Other release mechanisms include enteric release, osmotically active release, effervescent and sublingual release. OROS (Johnson & Johnson and Alza Corporation) and SODAS (Elan Technologies) are the most commercialised technologies in the oral controlled release drug delivery technology market.  

Key players in the global oral controlled release drug delivery technology market are focussing on capacity optimisation and technology partnerships, which ultimately increases contract development and manufacturing activities. Insights like this are the highlight of our new publication titled “Oral Controlled Release Drug Delivery Technology Market: Global Industry Analysis (2012 – 2016) and Opportunity Assessment (2017 – 2027).” While examining this market in detail our analysts have observed that the oral controlled release drug delivery technology industry has a limited time of approximately five years to facilitate effectiveness of technology for sustenance. Industry experts have noted that the best strategy to secure more valuable next-generation reformulated products is a meaningful adoption of drug delivery systems through partnerships between pharmaceutical companies and drug delivery companies.

Lack of sufficient investment opportunities in developing regions is keeping the market for oral controlled release drug delivery technologies limited to North America and Western Europe. Further, the launch of new chemical entities (NCE) is fuelling the need to develop innovative technologies at a low cost that can be readily adapted. Scaling up from the batch process is crucial and many times the prime reason for redundancy of technology.

Survey respondents’ inputs form a crucial part of our report

According to the technical support manager of BASF, “Targeted drug delivery, avoiding side effects and avoiding toxicity are key features fuelling the use of adequate polymeric excipients in the design and development of controlled release drugs.”

“International target markets such as Russia, CIS countries, India and China are growing at exponential rates owing to the heavy demand for CR technology,” states the Engineering Manager, Acino International AG.

The R & D Executive of Gattefosse further adds, “Particle engineering techniques such as melt extrusion, melt congealing, and spray atomisation are the biggest accelerators for developing controlled release drug delivery systems.”

Market sizing and forecasting

This report on the oral controlled release drug delivery technology market covers the market for drug delivery systems used to formulate controlled release drugs that are consumed orally. Increasing demand for reduced dosage, higher effectiveness through greater drug transport, higher action time and increased patient compliance to treatment schedules are factors fuelling the need for innovative controlled release technologies. The market size is measured in terms of value (US$) of oral controlled release formulations sold in a particular year. Accordingly, forecast factors have been developed to understand the adoption and growth rate for each of the individual technologies. Interviews have also been conducted with top contract manufacturing organisations to understand the comparative adoption of various technologies across drug classes and the process considerations behind them. Our research includes in-depth secondary research and primary research including discussions with formulation scientists, process engineers, academic professors and physicians. While a top-down approach has been primarily used to assess the market numbers, a bottom-up approach on a country level has been conducted in order to triangulate the values.

Market Taxonomy

By Region

By Drug Release System

By Dosage Form

  • North America

  • Latin America

  • Western Europe

  • Eastern Europe

  • APEJ

  • Japan

  • MEA

  • Diffusion Controlled Release System

  • Dissolution Controlled Release System

  • Osmotically Controlled Release System

  • Dissolution & Diffusion Controlled Release System

  • Ion Exchange Resins Controlled Release

  • Hydro-dynamically Balanced Drug Delivery System

  • Others

  • Solid Dosage Forms

  • Semisolid

  • Liquid/Suspensions

Research Methodology

We have adopted a systematic research approach while inspecting this report. In-depth secondary research is used to arrive at the overall market size, top industry players, top products and industry associations. Our analysts have formulated a detailed discussion guide to conduct exhaustive interviews with industry experts, industry players, distributors and retailers. Data is validated using the triangulation method, wherein primary and secondary research data along with Future Market Insights’ analysis contribute to the final data.

Oral Controlled Release Drug Delivery Technology Market Reports - Table of Contents

Table of Content

1. Executive Summary

1.1. Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Oral Controlled Release Drug Delivery Technology Market Opportunity Analysis 

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

3.3. Trends

3.4. Recent advancements in Oral Controlled Release Drug Delivery Technology

4. North America Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Regional Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Trends

4.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

4.3.1. U.S.

4.3.2. Canada

4.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

4.4.1. U.S.

4.4.2. Canada

4.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016

4.5.1. Diffusion Controlled Release System

4.5.2. Dissolution Controlled Release System

4.5.3. Osmotically Controlled Release System

4.5.4. Dissolution & Diffusion Controlled Release System

4.5.5. Ion Exchange Resins Controlled Release

4.5.6. Hydro-dynamically balanced drug delivery system

4.5.7. Others

4.6. Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027

4.6.1. Diffusion Controlled Release System

4.6.2. Dissolution Controlled Release System

4.6.3. Osmotically Controlled Release System

4.6.4. Dissolution & Diffusion Controlled Release System

4.6.5. Ion Exchange Resins Controlled Release

4.6.6. Hydro-dynamically balanced drug delivery system

4.6.7. Others

4.7. Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016

4.7.1. Solid Dosage Forms

4.7.2. Semisolid/Liquid/ Suspensions

4.8. Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027

4.8.1. Solid Dosage Forms

4.8.2. Semisolid/Liquid/ Suspension

4.9. Market Attractiveness Analysis

4.9.1. By Country

4.9.2. By Drug Release System

4.9.3. By Dosage Form

4.10.Key Representative Market Participants

4.11.Market Presence (Intensity Map)

4.12.Forecast Impact Factors

5. Latin America Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027

5.1. Introduction

5.2. Regional Market Dynamics

5.2.1. Drivers

5.2.2. Restraints

5.2.3. Trends

5.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

5.3.1. Brazil

5.3.2. Mexico

5.3.3. Rest of Latin America

5.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

5.4.1. Brazil

5.4.2. Mexico

5.4.3. Rest of Latin America

5.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016

5.5.1. Diffusion Controlled Release System

5.5.2. Dissolution Controlled Release System

5.5.3. Osmotically Controlled Release System

5.5.4. Dissolution & Diffusion Controlled Release System

5.5.5. Ion Exchange Resins Controlled Release

5.5.6. Hydro-dynamically balanced drug delivery system

5.5.7. Others

5.6. Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027

5.6.1. Diffusion Controlled Release System

5.6.2. Dissolution Controlled Release System

5.6.3. Osmotically Controlled Release System

5.6.4. Dissolution & Diffusion Controlled Release System

5.6.5. Ion Exchange Resins Controlled Release

5.6.6. Hydro-dynamically balanced drug delivery system

5.6.7. Others

5.7. Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016

5.7.1. Solid Dosage Forms

5.7.2. Semisolid/Liquid/ Suspensions

5.8. Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027

5.8.1. Solid Dosage Forms

5.8.2. Semisolid/Liquid/ Suspension

5.9. Market Attractiveness Analysis

5.9.1. By Country

5.9.2. By Drug Release System

5.9.3. By Dosage Form

5.10.Key Representative Market Participants

5.11.Market Presence (Intensity Map)

5.12.Forecast Impact Factors

6. Western Europe Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027

6.1. Introduction

6.2. Regional Market Dynamics

6.2.1. Drivers

6.2.2. Restraints

6.2.3. Trends

6.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

6.3.1. Germany

6.3.2. Italy

6.3.3. France

6.3.4. Spain

6.3.5. U.K.

6.3.6. Nordic

6.3.7. Rest of Western Europe

6.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

6.4.1. Germany

6.4.2. Italy

6.4.3. France

6.4.4. Spain

6.4.5. U.K.

6.4.6. Nordic

6.4.7. Rest of Western Europe

6.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016

6.5.1. Diffusion Controlled Release System

6.5.2. Dissolution Controlled Release System

6.5.3. Osmotically Controlled Release System

6.5.4. Dissolution & Diffusion Controlled Release System

6.5.5. Ion Exchange Resins Controlled Release

6.5.6. Hydro-dynamically balanced drug delivery system

6.5.7. Others

6.6. Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027

6.6.1. Diffusion Controlled Release System

6.6.2. Dissolution Controlled Release System

6.6.3. Osmotically Controlled Release System

6.6.4. Dissolution & Diffusion Controlled Release System

6.6.5. Ion Exchange Resins Controlled Release

6.6.6. Hydro-dynamically balanced drug delivery system

6.6.7. Others

6.7. Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016

6.7.1. Solid Dosage Forms

6.7.2. Semisolid/Liquid/ Suspensions

6.8. Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027

6.8.1. Solid Dosage Forms

6.8.2. Semisolid/Liquid/ Suspension

6.9. Market Attractiveness Analysis

6.9.1. By Country

6.9.2. By Drug Release System

6.9.3. By Dosage Form

6.10.Key Representative Market Participants

6.11.Market Presence (Intensity Map)

6.12.Forecast Impact Factors

7. Eastern Europe Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027

7.1. Introduction

7.2. Regional Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Trends

7.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

7.3.1. Russia

7.3.2. Poland

7.3.3. Rest of Eastern Europe

7.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

7.4.1. Russia

7.4.2. Poland

7.4.3. Rest of Eastern Europe

7.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016

7.5.1. Diffusion Controlled Release System

7.5.2. Dissolution Controlled Release System

7.5.3. Osmotically Controlled Release System

7.5.4. Dissolution & Diffusion Controlled Release System

7.5.5. Ion Exchange Resins Controlled Release

7.5.6. Hydro-dynamically balanced drug delivery system

7.5.7. Others

7.6. Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027

7.6.1. Diffusion Controlled Release System

7.6.2. Dissolution Controlled Release System

7.6.3. Osmotically Controlled Release System

7.6.4. Dissolution & Diffusion Controlled Release System

7.6.5. Ion Exchange Resins Controlled Release

7.6.6. Hydro-dynamically balanced drug delivery system

7.6.7. Others

7.7. Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016

7.7.1. Solid Dosage Forms

7.7.2. Semisolid/Liquid/ Suspensions

7.8. Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027

7.8.1. Solid Dosage Forms

7.8.2. Semisolid/Liquid/ Suspension

7.9. Market Attractiveness Analysis

7.9.1. By Country

7.9.2. By Drug Release System

7.9.3. By Dosage Form

7.10.Key Representative Market Participants

7.11.Market Presence (Intensity Map)

7.12.Forecast Impact Factors

8. Asia Pacific excluding Japan Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027

8.1. Introduction

8.2. Regional Market Dynamics

8.2.1. Drivers

8.2.2. Restraints

8.2.3. Trends

8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

8.3.1. China

8.3.2. India

8.3.3. ASEAN

8.3.4. Australia and New Zealand

8.3.5. Rest of APEJ

8.4. Market Size (US$ Mn) Forecast By Country, 2017–2027

8.4.1. China

8.4.2. India

8.4.3. ASEAN

8.4.4. Australia and New Zealand

8.4.5. Rest of APEJ

8.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016

8.5.1. Diffusion Controlled Release System

8.5.2. Dissolution Controlled Release System

8.5.3. Osmotically Controlled Release System

8.5.4. Dissolution & Diffusion Controlled Release System

8.5.5. Ion Exchange Resins Controlled Release

8.5.6. Hydro-dynamically balanced drug delivery system

8.5.7. Others

8.6. Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027

8.6.1. Diffusion Controlled Release System

8.6.2. Dissolution Controlled Release System

8.6.3. Osmotically Controlled Release System

8.6.4. Dissolution & Diffusion Controlled Release System

8.6.5. Ion Exchange Resins Controlled Release

8.6.6. Hydro-dynamically balanced drug delivery system

8.6.7. Others

8.7. Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016

8.7.1. Solid Dosage Forms

8.7.2. Semisolid/Liquid/ Suspensions

8.8. Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027

8.8.1. Solid Dosage Forms

8.8.2. Semisolid/Liquid/ Suspension

8.9. Market Attractiveness Analysis

8.9.1. By Country

8.9.2. By Drug Release System

8.9.3. By Dosage Form

8.10.Key Representative Market Participants

8.11.Market Presence (Intensity Map)

8.12.Forecast Impact Factors

9. Japan Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027

9.1. Introduction

9.2. Regional Market Dynamics

9.2.1. Drivers

9.2.2. Restraints

9.2.3. Trends

9.3. Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016

9.3.1. Diffusion Controlled Release System

9.3.2. Dissolution Controlled Release System

9.3.3. Osmotically Controlled Release System

9.3.4. Dissolution & Diffusion Controlled Release System

9.3.5. Ion Exchange Resins Controlled Release

9.3.6. Hydro-dynamically balanced drug delivery system

9.3.7. Others

9.4. Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027

9.4.1. Diffusion Controlled Release System

9.4.2. Dissolution Controlled Release System

9.4.3. Osmotically Controlled Release System

9.4.4. Dissolution & Diffusion Controlled Release System

9.4.5. Ion Exchange Resins Controlled Release

9.4.6. Hydro-dynamically balanced drug delivery system

9.4.7. Others

9.5. Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016

9.5.1. Solid Dosage Forms

9.5.2. Semisolid/Liquid/ Suspensions

9.6. Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027

9.6.1. Solid Dosage Forms

9.6.2. Semisolid/Liquid/ Suspension

9.7. Market Attractiveness Analysis

9.7.1. By Drug Release System

9.7.2. By Dosage Form

9.8. Key Representative Market Participants

9.9. Market Presence (Intensity Map)

9.10.Forecast Impact Factors

10. Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027

10.1.Introduction

10.2.Regional Market Dynamics

10.2.1. Drivers

10.2.2. Restraints

10.2.3. Trends

10.3.Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

10.3.1. GCC Countries

10.3.2. South Africa

10.3.3. Rest of MEA

10.4.Market Size (US$ Mn) Forecast By Country, 2017–2027

10.4.1. GCC Countries

10.4.2. South Africa

10.4.3. Rest of MEA

10.5.Historical Market Size (US$ Mn) Trend Analysis By Drug Release System, 2012–2016

10.5.1. Diffusion Controlled Release System

10.5.2. Dissolution Controlled Release System

10.5.3. Osmotically Controlled Release System

10.5.4. Dissolution & Diffusion Controlled Release System

10.5.5. Ion Exchange Resins Controlled Release

10.5.6. Hydro-dynamically balanced drug delivery system

10.5.7. Others

10.6.Market Size (US$ Mn) Forecast By Drug Release System, 2017–2027

10.6.1. Diffusion Controlled Release System

10.6.2. Dissolution Controlled Release System

10.6.3. Osmotically Controlled Release System

10.6.4. Dissolution & Diffusion Controlled Release System

10.6.5. Ion Exchange Resins Controlled Release

10.6.6. Hydro-dynamically balanced drug delivery system

10.6.7. Others

10.7.Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016

10.7.1. Solid Dosage Forms

10.7.2. Semisolid/Liquid/ Suspensions

10.8.Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027

10.8.1. Solid Dosage Forms

10.8.2. Semisolid/Liquid/ Suspension

10.9.Market Attractiveness Analysis

10.9.1. By Country

10.9.2. By Drug Release System

10.9.3. By Dosage Form

10.10. Key Representative Market Participants

10.11. Market Presence (Intensity Map)

10.12. Forecast Impact Factors

11. Forecast Factors: Relevance and Impact

12. Competition Landscape

12.1.Competition Dashboard

12.2.Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)

12.2.1. AstraZeneca Plc.

12.2.2. Bristol-Myers Squibb Company

12.2.3. Sun Pharmaceuticals Industries Ltd

12.2.4. Abbott Laboratories

12.2.5. Merck & Co. Inc.

12.2.6. Novartis AG

12.2.7. Pfizer Inc.

12.2.8. Mylan N.V.

12.2.9. Sanofi

12.2.10. F. Hoffman-La-Roche Ltd.

 12.2.11. Johnson & Johnson Services, Inc. 

12.2.12. Vectura Group plc. 

12.2.13. GlaxoSmithKline plc. 

13. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027, By Region

13.1.Introduction/Key Findings

13.2.Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016

13.2.1. North America

13.2.2. Latin America

13.2.3. Western Europe

13.2.4. Eastern Europe

13.2.5. Asia Pacific excluding Japan

13.2.6. Japan

13.2.7. Middle East & Africa

13.3.Market Size (US$ Mn) Forecast By Region, 2017–2027

13.3.1. North America

13.3.2. Latin America

13.3.3. Western Europe

13.3.4. Eastern Europe

13.3.5. Asia Pacific excluding Japan

13.3.6. Japan

13.3.7. Middle East & Africa

13.4.Market Attractiveness Analysis By Region

14. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027, By Drug Release Systems Type

14.1.Introduction/Key Findings

14.2.Historical Market Size (US$ Mn) Trend Analysis By Drug Release Systems , 2012–2016

14.2.1. Diffusion Controlled Release System

14.2.2. Dissolution Controlled Release System

14.2.3. Osmotically Controlled Release System

14.2.4. Dissolution & Diffusion Controlled Release System

14.2.5. Ion Exchange Resins Controlled Release

14.2.6. Hydro-dynamically balanced drug delivery system

14.2.7. Others

14.3.Market Size (US$ Mn) Forecast By Drug Release Systems, 2017–2027

14.3.1. Diffusion Controlled Release System

14.3.2. Dissolution Controlled Release System

14.3.3. Osmotically Controlled Release System

14.3.4. Dissolution & Diffusion Controlled Release System

14.3.5. Ion Exchange Resins Controlled Release

14.3.6. Hydro-dynamically balanced drug delivery system

14.3.7. Others

14.4.Market Attractiveness Analysis By Drug Release Systems

15. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027, By Dosage Form

15.1.Introduction/Key Findings

15.2.Historical Market Size (US$ Mn) Trend Analysis By Dosage Form, 2012–2016

15.2.1. Solid Dosage Forms

15.2.2. Semisolid/Liquid/ Suspension

15.3.Market Size (US$ Mn) Forecast By Dosage Form, 2017–2027

15.3.1. Solid Dosage Forms

15.3.2. Semisolid/Liquid/ Suspension

15.4.Market Attractiveness Analysis By Dosage

16. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027

16.1.Market Size and Y-o-Y Growth

16.2.Absolute $ Opportunity

16.3.Market Value Chain

16.4.Forecast Impact Factors

17. Assumptions and Acronyms Used

Oral Controlled Release Drug Delivery Technology Market Reports - List of Tables

Table 01: North America Oral Controlled Release Drug Delivery Technology Market  Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 02: North America Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Drug Release System (2012-2027)

Table 03: North America Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Dosage Form(2012-2027)

Table 04: Western Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 05: Western Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Drug Release System (2012-2027)

Table 06: Western Europe Oral Controlled Release Drug Delivery Technology Market  Value (US$ Mn) Analysis and Forecast, By Dosage Form(2012-2027)

Table 07: Eastern Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 08: Eastern Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Drug Release System (2012-2027)

Table 09: Eastern Europe Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Dosage Form(2012-2027)

Table 10: Latin America Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 11: Latin America Oral Controlled Release Drug Delivery Technology Market  Value (US$ Mn) Analysis and Forecast, By Drug Release System (2012-2027)

Table 12: Latin America Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Dosage Form(2012-2027)

Table 13: APEJ Oral Controlled Release Drug Delivery Technology Market  Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 14: APEJ Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Drug Release System (2012-2027)

Table 15: APEJ Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Dosage Form(2012-2027)

Table 16: Japan Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 17: Japan Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Drug Release System (2012-2027)

Table 18: Japan Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Dosage Form(2012-2027)

Table 19: MEA Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 20: MEA Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Drug Release System (2012-2027)

Table 21: MEA Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Dosage Form(2012-2027)

Table 22: Global Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Country (2012-2027)

Table 23: Global Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Drug Release System (2012-2027)

Table 24: Global Oral Controlled Release Drug Delivery Technology Market Value (US$ Mn) Analysis and Forecast, By Dosage Form (2012-2027)

Oral Controlled Release Drug Delivery Technology Market Reports - List of Figures

Figure 01 : North America Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2017)

Figure 02 : North America Oral Controlled Release Drug Delivery Technology  Market Value Share By Dosage Form (2017)

Figure 03 : North America Oral Controlled Release Drug Delivery Technology Market Value Share By Country (2017)

Figure 04: North America Oral Solid Dosage Pharmaceuticals Historical Market Size and Y-o-Y, 2012 - 2016

Figure 05: North America Oral Solid Dosage Pharmaceuticals Market Size (US$ Mn) & Y-o-Y analysis, 2016 - 2027

Figure 06: North America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Country, 2017–2027

Figure 07: North America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System, 2017–2027

Figure 08: North America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 09: Western Europe Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2017)

Figure 10: Western Europe Oral Controlled Release Drug Delivery Technology  Market Value Share By Dosage Form (2017)

Figure 11: Western Europe Oral Controlled Release Drug Delivery Technology Market Value Share By Country (2017)

Figure 12: Western Europe Oral Controlled Release Drug Delivery Technology Historical Market Size % Y-o-Y, 2012 - 2016

Figure 13: Western Europe Oral Controlled Release Drug Delivery Technology Market Size (US$ Mn) Y-o-Y analysis, 2016 – 2027

Figure 14: Western Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Country, 2017–2027

Figure 15: Western Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System, 2017–2027

Figure 16: Western Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 17: Eastern Europe Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2017)

Figure 18: Eastern Europe Oral Controlled Release Drug Delivery Technology  Market Value Share By Dosage Form (2017)

Figure 19: Eastern Europe Oral Controlled Release Drug Delivery Technology Market Value Share By Country (2017)

Figure 20: Eastern Europe Oral Controlled Release Drug Delivery Technology Historical Market Size & Y-o-Y Analysis, 2012 – 2016

Figure 21: Eastern Europe Oral Controlled Release Drug Delivery Technology Market Size (US$ Mn) & Y-o-Y Analysis, 2016 – 2027

Figure 22: Eastern Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Country, 2017–2027

Figure 23: Eastern Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System, 2017–2027

Figure 24: Eastern Europe Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 25: Latin America Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2017)

Figure 26: Latin America Oral Controlled Release Drug Delivery Technology  Market Value Share By Dosage Form (2017)

Figure 27: Latin America Oral Controlled Release Drug Delivery Technology Market Value Share By Country (2017)

Figure 28: Latin America Oral Controlled Release Drug Delivery Technology Historical Market Size & Y-o-Y Analysis, 2012 – 2016

Figure 29: Latin America Oral Controlled Release Drug Delivery Technology Market Size (US$ Mn) & Y-o-Y Analysis, 2016 – 2027

Figure 30: Latin America  Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Country, 2017–2027

Figure 31: Latin America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System, 2017–2027

Figure 32: Latin America Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 33: APEJ Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2017)

Figure 34: APEJ Oral Controlled Release Drug Delivery Technology  Market Value Share By Dosage Form (2017)

Figure 35: APEJ Oral Controlled Release Drug Delivery Technology Market Value Share By Country (2017)

Figure 36: APEJ Oral Controlled Release Drug Delivery Technology Historical Market Size & Y-o-Y Analysis 2012 - 2016

Figure 37: APEJ Oral Controlled Release Drug Delivery Technology Market Size (US$ Mn) & Y-o-Y Analysis, 2016 - 2027

Figure 38: APEJ Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Country, 2017–2027

Figure 39: APEJ  Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System, 2017–2027

Figure 40: APEJ Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 41 : Japan Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2017)

Figure 42: Japan Oral Controlled Release Drug Delivery Technology  Market Value Share By Dosage Form (2017)

Figure 43: Japan Oral Controlled Release Drug Delivery Technology Historical Market Size & Y-o-Y Analysis, 2012 - 2016

Figure 44: Japan Oral Controlled Release Drug Delivery Technology Market Size (US$ Mn) & Y-o-Y Analysis, 2016 - 2027

Figure 45: Japan Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System, 2017–2027

Figure 46: Japan Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 47: MEA Oral Controlled Release Drug Delivery Technology Market Value Share By Drug Release System (2017)

Figure 48: MEA Oral Controlled Release Drug Delivery Technology  Market Value Share By Dosage Form (2017)

Figure 49: MEA Oral Controlled Release Drug Delivery Technology Market Value Share By Country (2017)

Figure 50: MEA Oral Controlled Release Drug Delivery Technology Historical Market Size & Y-o-Y Analysis, 2012 - 2016

Figure 51: MEA Oral Controlled Release Drug Delivery Technology Market Size (US$ Mn) & Y-o-Y Analysis, 2016 - 2027

Figure 52: MEA Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Country, 2017–2027

Figure 53: MEA Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Drug Release System, 2017–2027

Figure 54: MEA Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis By Dosage Form, 2017–2027

Figure 55: Global Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis, By Region

Figure 56: Global Oral  Controlled Release Drug Delivery Technology Market Attractiveness Analysis, By Drug Release System

Figure 57: Global Oral Controlled Release Drug Delivery Technology Market Attractiveness Analysis, By Dosage Form

Figure 58: Global Oral Controlled Release Drug Delivery Technology Historical Market Size and Y-o-Y, 2012 - 2016

Figure 59: Global Oral Controlled Release Drug Delivery Technology Projected Market Size (US$ Mn) and Y-o-Y, 2017 – 2027

Figure 60: Global Oral Controlled Release Drug Delivery Technology Market Absolute $ Opportunity, 2012–2027